Allianz Asset Management’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
CCM
GC
ACM
MB
Allianz Asset Management's TECX Position: Q3 2021 in Review
Allianz Asset Management sold out of Tectonic Therapeutic (TECX) in Q3 2021, closing a stake of 3,321 shares — an estimated $354K sold.
Allianz Asset Management first reported a position in TECX in Q4 2019 and held it in 4 quarters. The position peaked at $649K in Q1 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q3 2021.
- Allianz Asset Management reported no remaining Tectonic Therapeutic position as of Q3 2021 after selling out during the quarter.
- Allianz Asset Management sold 3,321 Tectonic Therapeutic shares in Q3 2021, an estimated $354K.
- Allianz Asset Management first reported a position in Tectonic Therapeutic in Q4 2019 and held it in 4 quarters.
- Allianz Asset Management's Tectonic Therapeutic position peaked at $649K in Q1 2020.
- 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2021.
Based on Allianz Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.